Chi‐Long Chen

Taipei Medical University Hospital — Taiwan

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index3.8kcitations139works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic and Kidney Cyst Diseases(18), Virus-based gene therapy research(17), Viral-associated cancers and disorders(13), Pancreatic function and diabetes(12), Cancer-related gene regulation(9)

Publications138 total

Targeting ESR1 restores SQSTM1-dependent autophagy and sensitizes ER-positive breast cancer to oxidative and radiation stress
Cell Death Discovery·2025Open Access
Correction: Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Biomarker Research·2025Open Access
Abstract A048: Weakly supervised prediction of <i>EGFR</i> mutation status and early metastasis of lung adenocarcinoma whole slide histopathology images using artificial intelligence
Clinical Cancer Research·2025
Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of <scp>CHRNA9</scp> and <scp>IGF1R</scp>
The Journal of Pathology·2025· 1 cited
Histamine N-methyltransferase (HNMT) as a potential auxiliary biomarker for predicting adaptability to anti-HER2 drug treatment in breast cancer patients
Biomarker Research·2025· 3 citedOpen Access
B4GALT1-dependent galectin-8 binding with TGF-β receptor suppresses colorectal cancer progression and metastasis
Cell Death and Disease·2024· 8 citedOpen Access
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression
Cell Communication and Signaling·2024· 6 citedOpen Access
Abstract 3084: Aldob regulates fructose metabolism to confer ferroptosis and immune response in colorectal cancer harboring microsatellite instability
Cancer Research·2024
Abstract 6517: ALDOC as an indicator of HMGB1 blockade combined with checkpoint inhibitor based immunotherapy in GBM patients
Cancer Research·2024
Supplemental Figure S3 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Data from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions
The American Journal of Surgical Pathology·2024· 21 citedOpen Access
Supplemental Figure S3 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Supplemental Table S2 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Supplemental Figure S1 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Supplemental Table S6 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Supplemental Table S4 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Data from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024· 1 citedOpen Access
Supplemental Table S5 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
Supplemental Table S5 from Aneuploidy Landscape in Precursors of Ovarian Cancer
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Michael Hsiao(13), Yu‐Chan Chang(7), Chih‐Yeu Fang(7), Chia‐Yi Su(6), Yuan‐Feng Lin(6), Ann‐Lii Cheng(5), Ching‐Hwa Tsai(5), Yu-Chieh Lee(4), Jen‐Yang Chen(4), Tsung‐Ching Lai(4), Chung-Chun Wu(3), Yao Chang(3), Yi‐Hua Jan(3), Chih‐Jen Yang(3), Tai‐I Hsu(2), Li‐Tzong Chen(2), Sung‐Hsin Kuo(2), Yung‐Ming Jeng(2), Chia‐Huei Lee(2), Jan‐Show Chu(2)